Society of Hematologic Oncology

Free SOHO Membership: www.sohoonline.org

 

Acalabrutinib vs. SoC for R/R CLL: Do the Final Results of ASCEND Trial Confirm Favorable Efficacy and Safety of the BTKi Option?

0 views
December 14, 2020
Comments 0
Login to view comments. Click here to Login